Trial · NCT02410343
Results by group104
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 104
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Body Fat Mass at Baseline, Week 24 and Endpoint in Core Period | Placebo | Baseline | 24.38 | Standard Deviation 7.495 | kg |
| Body Fat Mass at Baseline, Week 24 and Endpoint in Core Period | TV-1106 | Baseline | 29.50 | Standard Deviation 10.922 | kg |
| Body Fat Mass at Baseline, Week 24 and Endpoint in Core Period | Placebo | Week 24 | 28.90 | Standard Deviation NA | kg |
| Body Fat Mass at Baseline, Week 24 and Endpoint in Core Period | TV-1106 | Week 24 | 31.80 | Standard Deviation NA | kg |
| Body Fat Mass at Baseline, Week 24 and Endpoint in Core Period | Placebo | Endpoint | 23.27 | Standard Deviation 7.389 | kg |
| Body Fat Mass at Baseline, Week 24 and Endpoint in Core Period | TV-1106 | Endpoint | 31.05 | Standard Deviation 13.256 | kg |
| Total Trunk Fat at Baseline, Week 24 and Endpoint in Core Period | Placebo | Baseline | 12.02 | Standard Deviation 4.716 | kg |
| Total Trunk Fat at Baseline, Week 24 and Endpoint in Core Period | TV-1106 | Baseline | 15.05 | Standard Deviation 5.041 | kg |
| Total Trunk Fat at Baseline, Week 24 and Endpoint in Core Period | Placebo | Week 24 | 15.60 | Standard Deviation NA | kg |
| Total Trunk Fat at Baseline, Week 24 and Endpoint in Core Period | TV-1106 | Week 24 | 12.60 | Standard Deviation NA | kg |
| Total Trunk Fat at Baseline, Week 24 and Endpoint in Core Period | Placebo | Endpoint | 11.20 | Standard Deviation 4.173 | kg |
| Total Trunk Fat at Baseline, Week 24 and Endpoint in Core Period | TV-1106 | Endpoint | 15.05 | Standard Deviation 6.369 | kg |
| Insulin-Like Growth Factor 1 Standard Deviation Score (IGF-I SDS) at Baseline, Week 24 and Endpoint in Core Period | Placebo | Baseline | -2.00 | Standard Deviation 0.978 | standard deviation score |
| Insulin-Like Growth Factor 1 Standard Deviation Score (IGF-I SDS) at Baseline, Week 24 and Endpoint in Core Period | TV-1106 | Baseline | -1.40 | Standard Deviation 0.545 | standard deviation score |
| Insulin-Like Growth Factor 1 Standard Deviation Score (IGF-I SDS) at Baseline, Week 24 and Endpoint in Core Period | Placebo | Week 24 | -2.00 | Standard Deviation NA | standard deviation score |
| Insulin-Like Growth Factor 1 Standard Deviation Score (IGF-I SDS) at Baseline, Week 24 and Endpoint in Core Period | TV-1106 | Week 24 | -1.30 | Standard Deviation NA | standard deviation score |
| Insulin-Like Growth Factor 1 Standard Deviation Score (IGF-I SDS) at Baseline, Week 24 and Endpoint in Core Period | Placebo | Endpoint | -1.66 | Standard Deviation 0.493 | standard deviation score |
| Insulin-Like Growth Factor 1 Standard Deviation Score (IGF-I SDS) at Baseline, Week 24 and Endpoint in Core Period | TV-1106 | Endpoint | -0.67 | Standard Deviation 0.896 | standard deviation score |
| Scored Analysis of Quality of Life Assessment of GH Deficiency in Adults (QoL-AGHDA) at Baseline, Week 24 and Endpoint in Core Period | Placebo | Baseline | 3.8 | Standard Deviation 5.46 | units on a scale |
| Scored Analysis of Quality of Life Assessment of GH Deficiency in Adults (QoL-AGHDA) at Baseline, Week 24 and Endpoint in Core Period | TV-1106 | Baseline | 9.6 | Standard Deviation 8.14 | units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02410343/results